RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index.

Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index.

Add to Collection
2021 Jul Others S Sundararajan, I Jayachandran… - Journal of …, 2021 - Springer

Full Author : ['Sundararajan, S', 'Jayachandran, I', 'Subramanian, S C', 'Anjana, R M', 'Balasubramanyam, M', 'Mohan, V', 'Venkatesan, B', 'Manickam, N']
Journal Title : Journal of endocrinological investigation
Chapter : Section3
Journal Year : 2021
Cited by : 17.0

PURPOSE: We earlier reported that Sestrin2 regulates monocyte activation and atherogenic events through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions. However, the statuses of Sestrins in diabetes and dyslipidemia are not known. We report..... Read More

Keywords : ["decrease sestrin level", "type diabetes", "atherogenic index", "severity", "patient", "dyslipidemia", "association"]
PubMed Link : https://link.springer.com/article/10.1007/s40618-020-01429-9
Google Scholar Link : https://scholar.google.com/scholar?cites=4809968951448930325&as_sdt=2005&sciodt=0,5&hl=en&num=20